Cleared Traditional

K152846 - HardyDisk AST Ceftolozane/Tazobactam

K152846 is the FDA 510(k) clearance for HardyDisk AST Ceftolozane/Tazobactam by Hardy Diagnostics. It is a Class 2 Microbiology device (product code JTN) cleared through the Traditional 510(k) pathway after a 56-day FDA review.

K152846 · Hardy Diagnostics · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2015
Decision
56d
Days
Class 2
Risk

K152846 is an FDA 510(k) clearance for the HardyDisk AST Ceftolozane/Tazobactam, (30/10ug)- C/T40. Classified as Susceptibility Test Discs, Antimicrobial (product code JTN), Class II - Special Controls.

Submitted by Hardy Diagnostics (Santa Maria, US). The FDA issued a Cleared decision on November 24, 2015 after a review of 56 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.1620 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Hardy Diagnostics devices

Submission Details

510(k) Number K152846 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 29, 2015
Decision Date November 24, 2015
Days to Decision 56 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
46d faster than avg
Panel avg: 102d · This submission: 56d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JTN Susceptibility Test Discs, Antimicrobial
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.1620
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - JTN Susceptibility Test Discs, Antimicrobial

All 282
Devices cleared under the same product code (JTN) and FDA review panel - the closest regulatory comparables to K152846.
HardyDisk AST Delafloxacin 5 µg (DLX5)
K171975 · Hardy Diagnostics · Aug 2017
HardyDisk Ceftolozane/Tazobactam, (30/10 ug)-C/T40
K170127 · Hardy Diagnostics · Mar 2017
HardyDisk AST Ceftazidime/Avibactam, (30/20ug)-CZA50
K152838 · Hardy Diagnostics · Nov 2015
BD BBL Sensi-Disc Ceftazidime Avibactam (30/20ug), Antimicrobial Susceptibility Test Disks
K152516 · Becton, Dickinson and Company · Oct 2015
HARDYDISK AST CEFTAROLINE, 30 UG MODEL Z939
K103538 · Hardy Diagnostics · Dec 2010
TELAVANCIN 30 UG, BBL SENSI-DISC
K100722 · Becton, Dickinson and Company · Mar 2010